PAA 2.50% 20.5¢ pharmaust limited

Ann: Stable Patient in MND trial reaches 6-months on MPL, page-6

  1. 1,066 Posts.
    lightbulb Created with Sketch. 2158
    Hi all,

    This is further advancement of the drug.

    I believe it's paramount news to the sufferer's of MND/ALS.

    I have been awaiting this announcement for a while now , as with other shareholders.

    Enjoy fellow HC members.
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.